Gilman Hill Asset Management’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-21,740
Closed -$130K 245
2026
Q1
$130K Hold
21,740
0.02% 221
2025
Q4
$156K Sell
21,740
-4,195
-16% -$33.1K 0.02% 221
2025
Q3
$277K Sell
25,935
-177,746
-87% -$1.74M 0.04% 184
2025
Q2
$1.97M Sell
203,681
-443,231
-69% -$4.57M 0.32% 88
2025
Q1
$9.63M Buy
646,912
+18,249
+3% +$281K 1.67% 12
2024
Q4
$9.38M Sell
628,663
-22,186
-3% -$362K 1.63% 10
2024
Q3
$12.5M Sell
650,849
-9,815
-1% -$203K 2.08% 5
2024
Q2
$13.7M Buy
660,664
+2,050
+0.3% +$40.7K 2.48% 1
2024
Q1
$12.4M Buy
658,614
+26,063
+4% +$447K 2.22% 3
2023
Q4
$9.12M Buy
632,551
+249,924
+65% +$3.4M 1.7% 13
2023
Q3
$6.64M Buy
382,627
+3,462
+0.9% +$72.2K 1.31% 24
2023
Q2
$7.89M Buy
+379,165
New +$8.24M 1.47% 19

Other funds holding OGN

Gilman Hill Asset Management's OGN Position: Q2 2026 in Review

Gilman Hill Asset Management sold out of Organon & Co (OGN) in Q2 2026, closing a stake of 21,740 shares — an estimated $130K sold.

Gilman Hill Asset Management first reported a position in OGN in Q2 2023 and held it in 12 quarters. The position peaked at $13.7M in Q2 2024. 107 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • Gilman Hill Asset Management reported no remaining Organon & Co position as of Q2 2026 after selling out during the quarter.
  • Gilman Hill Asset Management sold 21,740 Organon & Co shares in Q2 2026, an estimated $130K.
  • Gilman Hill Asset Management first reported a position in Organon & Co in Q2 2023 and held it in 12 quarters.
  • Gilman Hill Asset Management's Organon & Co position peaked at $13.7M in Q2 2024.
  • 107 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Gilman Hill Asset Management's 13F filing for Q2 2026, filed 9 Jul 2026.